Despite the relatively smaller GWAS sample size (21,468 for ER-negative breast cancer compared to 122,977 for overall breast cancer), ER-negative breast cancer showed stronger associations and higher genetic correlation with other cancers in the 5p15.33 region, as compared to ER-positive and overall breast cancer. This evidence concerns the gene ESR1 and cancer.